ProteoNic BV


: 4 avr. 2017


Recherche partenariat En recherche de financements
A propos

ProteoNic is seeking cooperation for the further advancement of its technology. ProteoNic is a life sciences company in possession of a validated and patented technology providing 2-3 times higher levels of recombinant proteins in mammalian cell vs. any current system. It is making license deals with pharma companies and CMO partners aiming for smarter, more cost-effective production of biopharmaceuticals. ProteoNic has collaborated in different European framework projects, for the development of cancer-specific antibodies.

Project activities and contributions offered to partner(s) comprise:

i) Production of recombinant biopharmaceutical proteins like biosimilars and difficult to express proteins in mammalian production hosts ( CHO GS), ii) development of new, genetically modified biopharmaceuticals, iii) expression construct development, iv) highly efficient screening for high-producing clones, v) biopharmaceutical protein production optimization as well as solving production and secretion issues.

Mots clés et domaine d'activité:

 Sciences Biologiques
 Biotechnologie
 Biotechnologie médicale
 Horizon Europe
 Union européenne
 INTERREG

Idées proposées

Appels à projets suivis
Pas d'appels à projets suivis!